Literature DB >> 31185190

Hepatosplenic γ-δ T-Cell Lymphoma: Who Is on Your Speed Dial?

Mridula Krishnan1, Matthew Lunning1.   

Abstract

Hepatosplenic γ-δ T-cell lymphoma, an exceptionally uncommon subtype of peripheral T-cell lymphomas, commonly presents with advanced-stage disease manifesting with hepatosplenomegaly, cytopenias, and constitutional symptoms. Management of this subset is challenging as a result of the unique presentation and refractory nature to conventional treatment approaches. There is a lack of consensus guidelines for up-front induction strategies, and the role of consolidative autologous or allogeneic stem-cell transplantation is controversial. Prospective studies are lacking, and treatment is often guided by literature on the basis of case series or single-institution studies, lending to expert opinions influencing treatment paradigms.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31185190     DOI: 10.1200/JOP.18.00594

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  2 in total

1.  Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.

Authors:  Qian Wang; Yibin Jiang; Qian Zhu; Yishan Duan; Xiaochen Chen; Ting Xu; Zhengming Jin; Caixia Li; Depei Wu; Haiwen Huang
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-15       Impact factor: 4.553

2.  Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.

Authors:  Francine M Foss; Steven M Horwitz; Monica Civallero; Monica Bellei; Luigi Marcheselli; Won Seog Kim; Maria E Cabrera; Ivan Dlouhy; Arnon Nagler; Ranjana H Advani; Emanuela A Pesce; Young-Hyeh Ko; Silvia Montoto; Carlos Chiattone; Alison Moskowitz; Michele Spina; Marina Cesaretti; Irene Biasoli; Massimo Federico
Journal:  Am J Hematol       Date:  2019-11-25       Impact factor: 10.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.